Case of epidermolysis bullosa acquisita with concomitant anti‐laminin‐332 antibodies

Subepidermal autoimmune blistering disease including bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, anti‐laminin‐γ1 pemphigoid, linear immunoglobulin A bullous disease and epidermolysis bullosa acquisita (EBA), are all characterized by direct immunofluorescence microscopy or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatology 2018-04, Vol.45 (4), p.472-474
Hauptverfasser: Nishida, Emi, Nishio, Eiichi, Murashima, Hiroko, Ishii, Norito, Hashimoto, Takashi, Morita, Akimichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 474
container_issue 4
container_start_page 472
container_title Journal of dermatology
container_volume 45
creator Nishida, Emi
Nishio, Eiichi
Murashima, Hiroko
Ishii, Norito
Hashimoto, Takashi
Morita, Akimichi
description Subepidermal autoimmune blistering disease including bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, anti‐laminin‐γ1 pemphigoid, linear immunoglobulin A bullous disease and epidermolysis bullosa acquisita (EBA), are all characterized by direct immunofluorescence microscopy or immunoglobulin deposition on the basement membrane zone. Among them, EBA is a rare acquired subepidermal autoimmune blistering disease of the skin and mucous membranes reactive with type VII collagen, a major component of the epidermal basement membrane zone. Anti‐laminin‐332‐type mucous membrane pemphigoid has pathogenic autoantibodies against laminin‐332, which is a basement membrane heterotrimeric protein composed of α3, β3 and γ2 laminin chains. We describe a 73‐year‐old Japanese man presenting with multiple, annular, tense blisters on the lower legs and oral lesions. Despite the severe clinical manifestations, the disease was successfully controlled by combination therapy of oral prednisolone and mizoribine. This case was confirmed to have autoantibodies to both type VII collagen and laminin‐332 α3 chain by indirect immunofluorescence of 1 mol NaCl‐split normal human skin, various immunoblot analyses and enzyme‐linked immunosorbent assays. This case was a rare case of EBA with concomitant anti‐laminin‐332 antibodies.
doi_str_mv 10.1111/1346-8138.14169
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1973020827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2028830467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3959-be909df6dd75c6d4e123e91f861a5d2700ff2472cdd2f589ce0b715497f76a523</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMotlbX7mTAjZtpc5lMkqXUeqPgRsFdyOSCKTOTdtKhdOcj-Iw-idOLXbgxcEjO4Ts_4QPgEsEh6s4IkSxPOSJ8iDKUiyPQP0yOQR8STlOcQdYDZzHOIMSCIngKelhgSLOc98H7WEWbBJfYuTe2qUK5jj4mRVuWIapE6UXro1-qZOWXH4kOtQ5V19bLpCv__flVqsrXvu5ehODtsAjG23gOTpwqo73Y3wPwdj95HT-m05eHp_HtNNVEUJEWVkBhXG4Mozo3mUWYWIEcz5GiBjMIncMZw9oY7CgX2sKCIZoJ5liuKCYDcLPLnTdh0dq4lJWP2palqm1oo0SCEYghx6xDr_-gs9A2dfc7iSHmnMAs31CjHaWbEGNjnZw3vlLNWiIoN9LlRrHcKJZb6d3G1T63LSprDvyv5Q6gO2DlS7v-L08-3012wT_k9Iz4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2028830467</pqid></control><display><type>article</type><title>Case of epidermolysis bullosa acquisita with concomitant anti‐laminin‐332 antibodies</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Nishida, Emi ; Nishio, Eiichi ; Murashima, Hiroko ; Ishii, Norito ; Hashimoto, Takashi ; Morita, Akimichi</creator><creatorcontrib>Nishida, Emi ; Nishio, Eiichi ; Murashima, Hiroko ; Ishii, Norito ; Hashimoto, Takashi ; Morita, Akimichi</creatorcontrib><description>Subepidermal autoimmune blistering disease including bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, anti‐laminin‐γ1 pemphigoid, linear immunoglobulin A bullous disease and epidermolysis bullosa acquisita (EBA), are all characterized by direct immunofluorescence microscopy or immunoglobulin deposition on the basement membrane zone. Among them, EBA is a rare acquired subepidermal autoimmune blistering disease of the skin and mucous membranes reactive with type VII collagen, a major component of the epidermal basement membrane zone. Anti‐laminin‐332‐type mucous membrane pemphigoid has pathogenic autoantibodies against laminin‐332, which is a basement membrane heterotrimeric protein composed of α3, β3 and γ2 laminin chains. We describe a 73‐year‐old Japanese man presenting with multiple, annular, tense blisters on the lower legs and oral lesions. Despite the severe clinical manifestations, the disease was successfully controlled by combination therapy of oral prednisolone and mizoribine. This case was confirmed to have autoantibodies to both type VII collagen and laminin‐332 α3 chain by indirect immunofluorescence of 1 mol NaCl‐split normal human skin, various immunoblot analyses and enzyme‐linked immunosorbent assays. This case was a rare case of EBA with concomitant anti‐laminin‐332 antibodies.</description><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.14169</identifier><identifier>PMID: 29205468</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Aged ; Autoantibodies ; Autoantibodies - blood ; Autoantibodies - immunology ; Biopsy ; Bullous pemphigoid ; Cell Adhesion Molecules - immunology ; Collagen ; Collagen Type VII - immunology ; Epidermolysis bullosa ; Epidermolysis bullosa acquisita ; Epidermolysis Bullosa Acquisita - blood ; Epidermolysis Bullosa Acquisita - drug therapy ; Epidermolysis Bullosa Acquisita - immunology ; Epidermolysis Bullosa Acquisita - pathology ; Humans ; Immunofluorescence ; Immunoglobulin A ; Immunoglobulins ; Immunosuppressive Agents - therapeutic use ; Kalinin ; Laminin ; laminin‐332 ; Leg ; Male ; Membrane proteins ; Mouth ; Mucous membrane ; mucous membrane pemphigoid ; Prednisolone ; Skin - immunology ; Skin - pathology ; Skin diseases ; Sodium chloride ; α3 laminin chain</subject><ispartof>Journal of dermatology, 2018-04, Vol.45 (4), p.472-474</ispartof><rights>2017 Japanese Dermatological Association</rights><rights>2017 Japanese Dermatological Association.</rights><rights>Copyright © 2018 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3959-be909df6dd75c6d4e123e91f861a5d2700ff2472cdd2f589ce0b715497f76a523</citedby><cites>FETCH-LOGICAL-c3959-be909df6dd75c6d4e123e91f861a5d2700ff2472cdd2f589ce0b715497f76a523</cites><orcidid>0000-0001-6563-1274</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.14169$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.14169$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29205468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nishida, Emi</creatorcontrib><creatorcontrib>Nishio, Eiichi</creatorcontrib><creatorcontrib>Murashima, Hiroko</creatorcontrib><creatorcontrib>Ishii, Norito</creatorcontrib><creatorcontrib>Hashimoto, Takashi</creatorcontrib><creatorcontrib>Morita, Akimichi</creatorcontrib><title>Case of epidermolysis bullosa acquisita with concomitant anti‐laminin‐332 antibodies</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>Subepidermal autoimmune blistering disease including bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, anti‐laminin‐γ1 pemphigoid, linear immunoglobulin A bullous disease and epidermolysis bullosa acquisita (EBA), are all characterized by direct immunofluorescence microscopy or immunoglobulin deposition on the basement membrane zone. Among them, EBA is a rare acquired subepidermal autoimmune blistering disease of the skin and mucous membranes reactive with type VII collagen, a major component of the epidermal basement membrane zone. Anti‐laminin‐332‐type mucous membrane pemphigoid has pathogenic autoantibodies against laminin‐332, which is a basement membrane heterotrimeric protein composed of α3, β3 and γ2 laminin chains. We describe a 73‐year‐old Japanese man presenting with multiple, annular, tense blisters on the lower legs and oral lesions. Despite the severe clinical manifestations, the disease was successfully controlled by combination therapy of oral prednisolone and mizoribine. This case was confirmed to have autoantibodies to both type VII collagen and laminin‐332 α3 chain by indirect immunofluorescence of 1 mol NaCl‐split normal human skin, various immunoblot analyses and enzyme‐linked immunosorbent assays. This case was a rare case of EBA with concomitant anti‐laminin‐332 antibodies.</description><subject>Aged</subject><subject>Autoantibodies</subject><subject>Autoantibodies - blood</subject><subject>Autoantibodies - immunology</subject><subject>Biopsy</subject><subject>Bullous pemphigoid</subject><subject>Cell Adhesion Molecules - immunology</subject><subject>Collagen</subject><subject>Collagen Type VII - immunology</subject><subject>Epidermolysis bullosa</subject><subject>Epidermolysis bullosa acquisita</subject><subject>Epidermolysis Bullosa Acquisita - blood</subject><subject>Epidermolysis Bullosa Acquisita - drug therapy</subject><subject>Epidermolysis Bullosa Acquisita - immunology</subject><subject>Epidermolysis Bullosa Acquisita - pathology</subject><subject>Humans</subject><subject>Immunofluorescence</subject><subject>Immunoglobulin A</subject><subject>Immunoglobulins</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kalinin</subject><subject>Laminin</subject><subject>laminin‐332</subject><subject>Leg</subject><subject>Male</subject><subject>Membrane proteins</subject><subject>Mouth</subject><subject>Mucous membrane</subject><subject>mucous membrane pemphigoid</subject><subject>Prednisolone</subject><subject>Skin - immunology</subject><subject>Skin - pathology</subject><subject>Skin diseases</subject><subject>Sodium chloride</subject><subject>α3 laminin chain</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKAzEUhoMotlbX7mTAjZtpc5lMkqXUeqPgRsFdyOSCKTOTdtKhdOcj-Iw-idOLXbgxcEjO4Ts_4QPgEsEh6s4IkSxPOSJ8iDKUiyPQP0yOQR8STlOcQdYDZzHOIMSCIngKelhgSLOc98H7WEWbBJfYuTe2qUK5jj4mRVuWIapE6UXro1-qZOWXH4kOtQ5V19bLpCv__flVqsrXvu5ehODtsAjG23gOTpwqo73Y3wPwdj95HT-m05eHp_HtNNVEUJEWVkBhXG4Mozo3mUWYWIEcz5GiBjMIncMZw9oY7CgX2sKCIZoJ5liuKCYDcLPLnTdh0dq4lJWP2palqm1oo0SCEYghx6xDr_-gs9A2dfc7iSHmnMAs31CjHaWbEGNjnZw3vlLNWiIoN9LlRrHcKJZb6d3G1T63LSprDvyv5Q6gO2DlS7v-L08-3012wT_k9Iz4</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Nishida, Emi</creator><creator>Nishio, Eiichi</creator><creator>Murashima, Hiroko</creator><creator>Ishii, Norito</creator><creator>Hashimoto, Takashi</creator><creator>Morita, Akimichi</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6563-1274</orcidid></search><sort><creationdate>201804</creationdate><title>Case of epidermolysis bullosa acquisita with concomitant anti‐laminin‐332 antibodies</title><author>Nishida, Emi ; Nishio, Eiichi ; Murashima, Hiroko ; Ishii, Norito ; Hashimoto, Takashi ; Morita, Akimichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3959-be909df6dd75c6d4e123e91f861a5d2700ff2472cdd2f589ce0b715497f76a523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Autoantibodies</topic><topic>Autoantibodies - blood</topic><topic>Autoantibodies - immunology</topic><topic>Biopsy</topic><topic>Bullous pemphigoid</topic><topic>Cell Adhesion Molecules - immunology</topic><topic>Collagen</topic><topic>Collagen Type VII - immunology</topic><topic>Epidermolysis bullosa</topic><topic>Epidermolysis bullosa acquisita</topic><topic>Epidermolysis Bullosa Acquisita - blood</topic><topic>Epidermolysis Bullosa Acquisita - drug therapy</topic><topic>Epidermolysis Bullosa Acquisita - immunology</topic><topic>Epidermolysis Bullosa Acquisita - pathology</topic><topic>Humans</topic><topic>Immunofluorescence</topic><topic>Immunoglobulin A</topic><topic>Immunoglobulins</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kalinin</topic><topic>Laminin</topic><topic>laminin‐332</topic><topic>Leg</topic><topic>Male</topic><topic>Membrane proteins</topic><topic>Mouth</topic><topic>Mucous membrane</topic><topic>mucous membrane pemphigoid</topic><topic>Prednisolone</topic><topic>Skin - immunology</topic><topic>Skin - pathology</topic><topic>Skin diseases</topic><topic>Sodium chloride</topic><topic>α3 laminin chain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nishida, Emi</creatorcontrib><creatorcontrib>Nishio, Eiichi</creatorcontrib><creatorcontrib>Murashima, Hiroko</creatorcontrib><creatorcontrib>Ishii, Norito</creatorcontrib><creatorcontrib>Hashimoto, Takashi</creatorcontrib><creatorcontrib>Morita, Akimichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nishida, Emi</au><au>Nishio, Eiichi</au><au>Murashima, Hiroko</au><au>Ishii, Norito</au><au>Hashimoto, Takashi</au><au>Morita, Akimichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case of epidermolysis bullosa acquisita with concomitant anti‐laminin‐332 antibodies</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2018-04</date><risdate>2018</risdate><volume>45</volume><issue>4</issue><spage>472</spage><epage>474</epage><pages>472-474</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><abstract>Subepidermal autoimmune blistering disease including bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, anti‐laminin‐γ1 pemphigoid, linear immunoglobulin A bullous disease and epidermolysis bullosa acquisita (EBA), are all characterized by direct immunofluorescence microscopy or immunoglobulin deposition on the basement membrane zone. Among them, EBA is a rare acquired subepidermal autoimmune blistering disease of the skin and mucous membranes reactive with type VII collagen, a major component of the epidermal basement membrane zone. Anti‐laminin‐332‐type mucous membrane pemphigoid has pathogenic autoantibodies against laminin‐332, which is a basement membrane heterotrimeric protein composed of α3, β3 and γ2 laminin chains. We describe a 73‐year‐old Japanese man presenting with multiple, annular, tense blisters on the lower legs and oral lesions. Despite the severe clinical manifestations, the disease was successfully controlled by combination therapy of oral prednisolone and mizoribine. This case was confirmed to have autoantibodies to both type VII collagen and laminin‐332 α3 chain by indirect immunofluorescence of 1 mol NaCl‐split normal human skin, various immunoblot analyses and enzyme‐linked immunosorbent assays. This case was a rare case of EBA with concomitant anti‐laminin‐332 antibodies.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29205468</pmid><doi>10.1111/1346-8138.14169</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-6563-1274</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2018-04, Vol.45 (4), p.472-474
issn 0385-2407
1346-8138
language eng
recordid cdi_proquest_miscellaneous_1973020827
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Autoantibodies
Autoantibodies - blood
Autoantibodies - immunology
Biopsy
Bullous pemphigoid
Cell Adhesion Molecules - immunology
Collagen
Collagen Type VII - immunology
Epidermolysis bullosa
Epidermolysis bullosa acquisita
Epidermolysis Bullosa Acquisita - blood
Epidermolysis Bullosa Acquisita - drug therapy
Epidermolysis Bullosa Acquisita - immunology
Epidermolysis Bullosa Acquisita - pathology
Humans
Immunofluorescence
Immunoglobulin A
Immunoglobulins
Immunosuppressive Agents - therapeutic use
Kalinin
Laminin
laminin‐332
Leg
Male
Membrane proteins
Mouth
Mucous membrane
mucous membrane pemphigoid
Prednisolone
Skin - immunology
Skin - pathology
Skin diseases
Sodium chloride
α3 laminin chain
title Case of epidermolysis bullosa acquisita with concomitant anti‐laminin‐332 antibodies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T20%3A52%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20of%20epidermolysis%20bullosa%20acquisita%20with%20concomitant%20anti%E2%80%90laminin%E2%80%90332%20antibodies&rft.jtitle=Journal%20of%20dermatology&rft.au=Nishida,%20Emi&rft.date=2018-04&rft.volume=45&rft.issue=4&rft.spage=472&rft.epage=474&rft.pages=472-474&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.14169&rft_dat=%3Cproquest_cross%3E2028830467%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2028830467&rft_id=info:pmid/29205468&rfr_iscdi=true